Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

Personalized Breast Cancer Trial Advances 7 Drugs

Laura Esserman

A clinical trial with a design that allows for changes in its processes to meet the needs of individual patients says its results helped advance 7 new drugs for breast cancer into review by FDA. . . . → Read More: Personalized Breast Cancer Trial Advances 7 Drugs

You Call That a Drug Pricing Policy?

Pills on money

Although he called it, “the most sweeping action in history to lower the price of prescription drugs for the American people,” the plan was anything but that. . . . → Read More: You Call That a Drug Pricing Policy?

Drug Price Report Calls for Govt Negotiation, More Generics

A panel convened by the National Academies calls for the federal government to use its buying power to negotiate better drug prices for consumers. . . . → Read More: Drug Price Report Calls for Govt Negotiation, More Generics

Here’s What a Real Opioid Emergency Looks Like

Let’s be clear — the limited steps ordered by the president to reduce the numbers of people addicted to opioids don’t look anything like a response to an emergency. . . . → Read More: Here’s What a Real Opioid Emergency Looks Like

Flashback: Drug Pricing Reform Even Big Pharma Might Like

Science & Enterprise is taking a break From 2 to 13 October. Until then, we will re-run some of our recent special reports. Our regular posts will return on 16 October.

(TBIT/Pixabay)

2 May 2016. At a press event in Washington, D.C. last week, Representative Lloyd Doggett of Texas, a champion of lower prescription . . . → Read More: Flashback: Drug Pricing Reform Even Big Pharma Might Like

Immigration Crackdown “a Disaster” for U.S. Science

A panel of research executives from American universities said the current hostility to immigration in the U.S. is causing fear among many researchers and could have a serious impact on science. . . . → Read More: Immigration Crackdown “a Disaster” for U.S. Science

Precision Medicine, “My Hope for the Future”

A meeting on Capitol Hill in Washington, D.C. today heard about one person’s struggle with cystic fibrosis and her hope for precision medicine to provide a cure. . . . → Read More: Precision Medicine, “My Hope for the Future”

Patent Office Decides for Broad and Editas in Crispr Case

The U.S. Patent and Trademark Office decided that the gene editing processes developed by Broad Institute and licensed to Editas Medicine do not interfere with techniques for genome editing created by University of California at Berkeley. . . . → Read More: Patent Office Decides for Broad and Editas in Crispr Case

Science Org. CEO: Trump Order “Contrary to Science”

The chief executive officer of the world’s largest general science organization called the Trump administration’s order detaining travelers from Muslim countries to the U.S., including scientists and students, “contrary to the spirit of science.” . . . → Read More: Science Org. CEO: Trump Order “Contrary to Science”

News Blackout Imposed on U.S. Science Agencies [Updated]

Multiple news services today are reporting that the Trump administration is ordering several U.S. government agencies conducting or funding scientific research to cease discussing its activities with the media or public officials. . . . → Read More: News Blackout Imposed on U.S. Science Agencies [Updated]